$0.8219
-0.35-29.75%
Last update: Oct 23, 3:52 PM
BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) Stock Price, Quote, News & History
BCLIOTCQB
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky...
You can purchase shares of BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI) through any online brokerage.
There are no as such competitors for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
There is no analysis for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. to provide a consensus price target.
The stock price for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is $0.8219 last updated October 23, 2026 at 3:52 PM EDT.
There are no upcoming dividends for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
Brainstorm Cell Therapeutics Inc is a biotechnology company committed to the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis, progressive...
